The global Non-Invasive Glucose Monitoring market size was valued at US$ 4986.4 million in 2023. With growing demand in downstream market, the Non-Invasive Glucose Monitoring is forecast to a readjusted size of US$ 6311.3 million by 2030 with a CAGR of 3.4% during review period.
The research report highlights the growth potential of the global Non-Invasive Glucose Monitoring market. Non-Invasive Glucose Monitoring are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Non-Invasive Glucose Monitoring. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Non-Invasive Glucose Monitoring market.
Non-invasive glucose monitoring refers to blood glucose measurement methods that do not require the collection of a blood sample. These methods include technologies such as optical sensors, spectroscopy, and transdermal glucose monitoring.
The market for non-invasive glucose monitoring is driven by the growing demand for painless and convenient glucose monitoring solutions, especially among individuals with diabetes who require frequent blood glucose testing. Technological advancements in non-invasive glucose monitoring devices, such as wearable sensors and mobile health applications, have also impacted the market's growth.
Key Features:
The report on Non-Invasive Glucose Monitoring market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Non-Invasive Glucose Monitoring market. It may include historical data, market segmentation by Type (e.g., Wearable Blood Glucose Monitoring Systems, Table Top Blood Glucose Monitoring Systems), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Non-Invasive Glucose Monitoring market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Non-Invasive Glucose Monitoring market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Non-Invasive Glucose Monitoring industry. This include advancements in Non-Invasive Glucose Monitoring technology, Non-Invasive Glucose Monitoring new entrants, Non-Invasive Glucose Monitoring new investment, and other innovations that are shaping the future of Non-Invasive Glucose Monitoring.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Non-Invasive Glucose Monitoring market. It includes factors influencing customer ' purchasing decisions, preferences for Non-Invasive Glucose Monitoring product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Non-Invasive Glucose Monitoring market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Non-Invasive Glucose Monitoring market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Non-Invasive Glucose Monitoring market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Non-Invasive Glucose Monitoring industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Non-Invasive Glucose Monitoring market.
Market Segmentation:
Non-Invasive Glucose Monitoring market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Wearable Blood Glucose Monitoring Systems
Table Top Blood Glucose Monitoring Systems
Segmentation by application
Hospitals
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Medtronic
Roche
Bayer AG
B. Braun
Nipro Diagnostics
Life Scan Inc.(J&J)
Arkray Devices
Nova Biomedical
Bionime Corporation
Sinocare
Hybio Pharmaceutical
Lepu Medical
Yuyue Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Non-Invasive Glucose Monitoring market?
What factors are driving Non-Invasive Glucose Monitoring market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-Invasive Glucose Monitoring market opportunities vary by end market size?
How does Non-Invasive Glucose Monitoring break out type, application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Non-Invasive Glucose Monitoring Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Non-Invasive Glucose Monitoring by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Non-Invasive Glucose Monitoring by Country/Region, 2019, 2023 & 2030
2.2 Non-Invasive Glucose Monitoring Segment by Type
2.2.1 Wearable Blood Glucose Monitoring Systems
2.2.2 Table Top Blood Glucose Monitoring Systems
2.3 Non-Invasive Glucose Monitoring Sales by Type
2.3.1 Global Non-Invasive Glucose Monitoring Sales Market Share by Type (2019-2024)
2.3.2 Global Non-Invasive Glucose Monitoring Revenue and Market Share by Type (2019-2024)
2.3.3 Global Non-Invasive Glucose Monitoring Sale Price by Type (2019-2024)
2.4 Non-Invasive Glucose Monitoring Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Non-Invasive Glucose Monitoring Sales by Application
2.5.1 Global Non-Invasive Glucose Monitoring Sale Market Share by Application (2019-2024)
2.5.2 Global Non-Invasive Glucose Monitoring Revenue and Market Share by Application (2019-2024)
2.5.3 Global Non-Invasive Glucose Monitoring Sale Price by Application (2019-2024)
3 Global Non-Invasive Glucose Monitoring by Company
3.1 Global Non-Invasive Glucose Monitoring Breakdown Data by Company
3.1.1 Global Non-Invasive Glucose Monitoring Annual Sales by Company (2019-2024)
3.1.2 Global Non-Invasive Glucose Monitoring Sales Market Share by Company (2019-2024)
3.2 Global Non-Invasive Glucose Monitoring Annual Revenue by Company (2019-2024)
3.2.1 Global Non-Invasive Glucose Monitoring Revenue by Company (2019-2024)
3.2.2 Global Non-Invasive Glucose Monitoring Revenue Market Share by Company (2019-2024)
3.3 Global Non-Invasive Glucose Monitoring Sale Price by Company
3.4 Key Manufacturers Non-Invasive Glucose Monitoring Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-Invasive Glucose Monitoring Product Location Distribution
3.4.2 Players Non-Invasive Glucose Monitoring Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Non-Invasive Glucose Monitoring by Geographic Region
4.1 World Historic Non-Invasive Glucose Monitoring Market Size by Geographic Region (2019-2024)
4.1.1 Global Non-Invasive Glucose Monitoring Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Non-Invasive Glucose Monitoring Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Non-Invasive Glucose Monitoring Market Size by Country/Region (2019-2024)
4.2.1 Global Non-Invasive Glucose Monitoring Annual Sales by Country/Region (2019-2024)
4.2.2 Global Non-Invasive Glucose Monitoring Annual Revenue by Country/Region (2019-2024)
4.3 Americas Non-Invasive Glucose Monitoring Sales Growth
4.4 APAC Non-Invasive Glucose Monitoring Sales Growth
4.5 Europe Non-Invasive Glucose Monitoring Sales Growth
4.6 Middle East & Africa Non-Invasive Glucose Monitoring Sales Growth
5 Americas
5.1 Americas Non-Invasive Glucose Monitoring Sales by Country
5.1.1 Americas Non-Invasive Glucose Monitoring Sales by Country (2019-2024)
5.1.2 Americas Non-Invasive Glucose Monitoring Revenue by Country (2019-2024)
5.2 Americas Non-Invasive Glucose Monitoring Sales by Type
5.3 Americas Non-Invasive Glucose Monitoring Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-Invasive Glucose Monitoring Sales by Region
6.1.1 APAC Non-Invasive Glucose Monitoring Sales by Region (2019-2024)
6.1.2 APAC Non-Invasive Glucose Monitoring Revenue by Region (2019-2024)
6.2 APAC Non-Invasive Glucose Monitoring Sales by Type
6.3 APAC Non-Invasive Glucose Monitoring Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Non-Invasive Glucose Monitoring by Country
7.1.1 Europe Non-Invasive Glucose Monitoring Sales by Country (2019-2024)
7.1.2 Europe Non-Invasive Glucose Monitoring Revenue by Country (2019-2024)
7.2 Europe Non-Invasive Glucose Monitoring Sales by Type
7.3 Europe Non-Invasive Glucose Monitoring Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Non-Invasive Glucose Monitoring by Country
8.1.1 Middle East & Africa Non-Invasive Glucose Monitoring Sales by Country (2019-2024)
8.1.2 Middle East & Africa Non-Invasive Glucose Monitoring Revenue by Country (2019-2024)
8.2 Middle East & Africa Non-Invasive Glucose Monitoring Sales by Type
8.3 Middle East & Africa Non-Invasive Glucose Monitoring Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-Invasive Glucose Monitoring
10.3 Manufacturing Process Analysis of Non-Invasive Glucose Monitoring
10.4 Industry Chain Structure of Non-Invasive Glucose Monitoring
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-Invasive Glucose Monitoring Distributors
11.3 Non-Invasive Glucose Monitoring Customer
12 World Forecast Review for Non-Invasive Glucose Monitoring by Geographic Region
12.1 Global Non-Invasive Glucose Monitoring Market Size Forecast by Region
12.1.1 Global Non-Invasive Glucose Monitoring Forecast by Region (2025-2030)
12.1.2 Global Non-Invasive Glucose Monitoring Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Non-Invasive Glucose Monitoring Forecast by Type
12.7 Global Non-Invasive Glucose Monitoring Forecast by Application
13 Key Players Analysis
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Non-Invasive Glucose Monitoring Product Portfolios and Specifications
13.1.3 Abbott Non-Invasive Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Medtronic
13.2.1 Medtronic Company Information
13.2.2 Medtronic Non-Invasive Glucose Monitoring Product Portfolios and Specifications
13.2.3 Medtronic Non-Invasive Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Medtronic Main Business Overview
13.2.5 Medtronic Latest Developments
13.3 Roche
13.3.1 Roche Company Information
13.3.2 Roche Non-Invasive Glucose Monitoring Product Portfolios and Specifications
13.3.3 Roche Non-Invasive Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Roche Main Business Overview
13.3.5 Roche Latest Developments
13.4 Bayer AG
13.4.1 Bayer AG Company Information
13.4.2 Bayer AG Non-Invasive Glucose Monitoring Product Portfolios and Specifications
13.4.3 Bayer AG Non-Invasive Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Bayer AG Main Business Overview
13.4.5 Bayer AG Latest Developments
13.5 B. Braun
13.5.1 B. Braun Company Information
13.5.2 B. Braun Non-Invasive Glucose Monitoring Product Portfolios and Specifications
13.5.3 B. Braun Non-Invasive Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 B. Braun Main Business Overview
13.5.5 B. Braun Latest Developments
13.6 Nipro Diagnostics
13.6.1 Nipro Diagnostics Company Information
13.6.2 Nipro Diagnostics Non-Invasive Glucose Monitoring Product Portfolios and Specifications
13.6.3 Nipro Diagnostics Non-Invasive Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Nipro Diagnostics Main Business Overview
13.6.5 Nipro Diagnostics Latest Developments
13.7 Life Scan Inc.(J&J)
13.7.1 Life Scan Inc.(J&J) Company Information
13.7.2 Life Scan Inc.(J&J) Non-Invasive Glucose Monitoring Product Portfolios and Specifications
13.7.3 Life Scan Inc.(J&J) Non-Invasive Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Life Scan Inc.(J&J) Main Business Overview
13.7.5 Life Scan Inc.(J&J) Latest Developments
13.8 Arkray Devices
13.8.1 Arkray Devices Company Information
13.8.2 Arkray Devices Non-Invasive Glucose Monitoring Product Portfolios and Specifications
13.8.3 Arkray Devices Non-Invasive Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Arkray Devices Main Business Overview
13.8.5 Arkray Devices Latest Developments
13.9 Nova Biomedical
13.9.1 Nova Biomedical Company Information
13.9.2 Nova Biomedical Non-Invasive Glucose Monitoring Product Portfolios and Specifications
13.9.3 Nova Biomedical Non-Invasive Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Nova Biomedical Main Business Overview
13.9.5 Nova Biomedical Latest Developments
13.10 Bionime Corporation
13.10.1 Bionime Corporation Company Information
13.10.2 Bionime Corporation Non-Invasive Glucose Monitoring Product Portfolios and Specifications
13.10.3 Bionime Corporation Non-Invasive Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Bionime Corporation Main Business Overview
13.10.5 Bionime Corporation Latest Developments
13.11 Sinocare
13.11.1 Sinocare Company Information
13.11.2 Sinocare Non-Invasive Glucose Monitoring Product Portfolios and Specifications
13.11.3 Sinocare Non-Invasive Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Sinocare Main Business Overview
13.11.5 Sinocare Latest Developments
13.12 Hybio Pharmaceutical
13.12.1 Hybio Pharmaceutical Company Information
13.12.2 Hybio Pharmaceutical Non-Invasive Glucose Monitoring Product Portfolios and Specifications
13.12.3 Hybio Pharmaceutical Non-Invasive Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Hybio Pharmaceutical Main Business Overview
13.12.5 Hybio Pharmaceutical Latest Developments
13.13 Lepu Medical
13.13.1 Lepu Medical Company Information
13.13.2 Lepu Medical Non-Invasive Glucose Monitoring Product Portfolios and Specifications
13.13.3 Lepu Medical Non-Invasive Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Lepu Medical Main Business Overview
13.13.5 Lepu Medical Latest Developments
13.14 Yuyue Medical
13.14.1 Yuyue Medical Company Information
13.14.2 Yuyue Medical Non-Invasive Glucose Monitoring Product Portfolios and Specifications
13.14.3 Yuyue Medical Non-Invasive Glucose Monitoring Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Yuyue Medical Main Business Overview
13.14.5 Yuyue Medical Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
